Maggi C A, Zagorodnyuk V, Giuliani S
Pharmacology Department, A. Menarini Pharmaceuticals, Florence, Italy.
Regul Pept. 1994 Oct 21;53(3):259-74. doi: 10.1016/0167-0115(94)90174-0.
In the presence of atropine (1 microM), guanethidine (3 microM) and of the tachykinin NK1 (SR 140,333 0.1 microM) and NK2 (GR 94,800 3 microM) receptor antagonists, the application of the tachykinin NK3 receptor selective agonist senktide, or that of neurokinin B, produced concentration-dependent sustained nonadrenergic noncholinergic (NANC) relaxation of mucosa-free circular muscle strips from the guinea-pig proximal colon. The maximal relaxant responses to senktide and neurokinin B were similar, approaching about 70% of the relaxation to 1 microM isoprenaline. Senktide (EC50 0.16 nM) was about 64-fold more potent than neurokinin B (EC50 10.3 nM). When tested in the presence of peptidase inhibitors (thiorphan 1 microM, captopril 1 microM and amastatin 10 microM), neurokinin B (EC50 0.24 nM) was equipotent to senktide (EC50 0.19 nM). At 1 nM, substance P and neurokinin A were ineffective in producing a NANC relaxation of the colon. At 1 microM substance P, neurokinin A and neurokinin B produced a NANC relaxation, which averaged 23, 40 and 79% of the maximal response to isoprenaline, respectively. In the presence of peptidase inhibitors, 1 nM substance P and neurokinin A produced threshold relaxant responses and, at 1 microM, the three natural tachykinins were equieffective (66 +/- 8, 72 +/- 5 and 75 +/- 5% of the relaxation to isoprenaline for substance P, neurokinin A and neurokinin B, respectively). The relaxant response to 1 nM senktide (producing about 70-80% of its maximal effect) was totally abolished by 1 microM tetrodotoxin and largely (> 90%) inhibited by 100 microM L-nitroarginine (L-NOARG). The inhibition by L-NOARG was partially reversed by L-arginine (3 mM) but not D-arginine. Apamin (1 microM) produced a slight (about 20%) inhibition of the response to senktide. The peptide blocker of N-type calcium channels, omega-conotoxin (0.1 microM) was ineffective. In sucrose gap electrophysiological experiments, superfusion with senktide (0.1 microM for 10 s) produced a slowly developing and prolonged hyperpolarization of the membrane and relaxation. Both effects were inhibited by L-NOARG while apamin had no effect. These findings indicate that a neuronal NK3 receptor mediates NANC hyperpolarization and relaxation of the circular muscle of the guinea-pig proximal colon, principally through the release of NO. NO generation/release in response to NK3 receptor stimulation does not require calcium influx through N-type calcium channels.
在存在阿托品(1微摩尔)、胍乙啶(3微摩尔)以及速激肽NK1(SR 140,333 0.1微摩尔)和NK2(GR 94,800 3微摩尔)受体拮抗剂的情况下,应用速激肽NK3受体选择性激动剂速激肽或神经激肽B,可使豚鼠近端结肠无黏膜环行肌条产生浓度依赖性的持续性非肾上腺素能非胆碱能(NANC)舒张。速激肽和神经激肽B的最大舒张反应相似,接近对1微摩尔异丙肾上腺素舒张反应的70%左右。速激肽(EC50为0.16纳摩尔)的效力比神经激肽B(EC50为10.3纳摩尔)强约64倍。当在肽酶抑制剂(硫磷酰胺1微摩尔、卡托普利1微摩尔和氨肽酶抑制剂10微摩尔)存在下进行测试时,神经激肽B(EC50为0.24纳摩尔)与速激肽(EC50为0.19纳摩尔)效力相当。在1纳摩尔时,P物质和神经激肽A对结肠产生NANC舒张无效。在1微摩尔时,P物质、神经激肽A和神经激肽B产生NANC舒张,分别平均为对异丙肾上腺素最大反应的23%、40%和79%。在肽酶抑制剂存在下,1纳摩尔的P物质和神经激肽A产生阈下舒张反应,在1微摩尔时,三种天然速激肽效果相当(P物质、神经激肽A和神经激肽B对异丙肾上腺素舒张反应的百分比分别为66±8%、72±5%和75±5%)。对1纳摩尔速激肽的舒张反应(产生其最大效应的约70 - 80%)被1微摩尔河豚毒素完全消除,并被100微摩尔L - 硝基精氨酸(L - NOARG)大幅(> 90%)抑制。L - NOARG的抑制作用可被L - 精氨酸(3毫摩尔)部分逆转,但不能被D - 精氨酸逆转。蜂毒明肽(1微摩尔)对速激肽的反应产生轻微(约20%)抑制。N型钙通道的肽类阻断剂ω - 芋螺毒素(0.1微摩尔)无效。在蔗糖间隙电生理实验中,用速激肽(0.1微摩尔,持续10秒)灌流可产生缓慢发展且持续时间长的膜超极化和舒张。这两种效应均被L - NOARG抑制,而蜂毒明肽无作用。这些发现表明,神经元NK3受体介导豚鼠近端结肠环行肌的NANC超极化和舒张,主要是通过一氧化氮的释放。响应NK3受体刺激产生的一氧化氮生成/释放不需要通过N型钙通道的钙内流。